Z79.81 - Long term (current) use of agents affecting estrogen receptors and estrogen levels
- Applicable to Long term (current) use of agents affecting estrogen receptors and estrogen levels
- The 2025 edition of ICD10-CM Z79.81 became effective on October 1, 2024.
- This is the American ICD10-CM version of Z79.81 - other international versions of ICD10 Z79.81 may differ.
- Z79.81 is a Non-Billable / Non-Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- Z79.81 Code should not be used for billing or reimbursement purposes as there are multiple ICD-10 CM codes below it that contain a greater level of detail.
- Z79.81 - Long term (current) use of agents affecting estrogen receptors and estrogen levels
- Z79.81 - Long term (current) use of agents affecting estrogen receptors and estrogen levels
- Z79.810 - Long term (current) use of selective estrogen receptor modulators (SERMs)
- Z79.811 - Long term (current) use of aromatase inhibitors
- Z79.818 - Long term (current) use of other agents affecting estrogen receptors and estrogen levels
Code Additional Code
- code, if applicable, to identify:
- estrogen receptor positive status (Z17.0)
- family history of breast cancer (Z80.3)
- genetic susceptibility to malignant neoplasm (cancer) (Z15.0-)
- personal history of breast cancer (Z85.3)
- personal history of prostate cancer (Z85.46)
- postmenopausal status (Z78.0)
Type 1 Excludes
- hormone replacement therapy (Z79.890)
codefirst
- , if applicable:
- malignant neoplasm of breast (C50.-)
- malignant neoplasm of prostate (C61)
The following codes above Z79.81 contain annotation back-references that may be applicable to Z79.81:
Chapter: Z00-Z99 Factors influencing health status and contact with health services
Category: Z79 Long term (current) drug therapy
Non-Billable/Non-Specific Code
Browse other similar CM codes
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd-10code.com